Skip to Content

Tag: John Rademacher


Option Care saw ‘balanced growth’ in Q3

Specialty Providers

Option Care saw ‘balanced growth’ in Q3

October 30, 2025HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported net revenue of $1.435 billion for the third quarter 2025, a 12.2% increase over the same quarter in 2024.   Other financial results for the quarter:  Gross profit of $272.9 million, up 6.3%  Net income of $51.8 million, down 3.8%  Adjusted EBITDA of $119.5 million, up 3.4%  YTD cash provided by operating activities of $222.6 million  Repurchased $62.5...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care fueled by balanced portfolio, strong margins, strategic expansion

August 1, 2025Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health delivered a strong second quarter, reporting 15.4% revenue growth to $1.416 billion, with both its acute and chronic care portfolios showing mid-teen gains.  “The acute therapy growth we delivered in the quarter was notably higher than we believe the overall market to be growing,” said CFO Mike Shapiro on a recent call to discuss the company’s earnings. “(In the) acute portfolio, the product margins are north of 50%. The...

Home Infusion Therapy, John Rademacher, Option Care Health, Stelara


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care is ‘resilient’ in Q2, CEO says

July 30, 2025HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of about $1.416 billion for the second quarter of 2025, an increase of 15.4% over the same period in 2024. Gross profit was $269 million, or 19% of net revenue, up 7.9%.  Net income was $50.5 million vs. $53 million.  “I am proud of the second quarter performance and the Option Care Health team's ability to show resilience in a dynamic marketplace,” said John Rademacher, CEO. “We continue to execute...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Tariffs, tech, payer alignment top of mind at Option Care

May 2, 2025Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care neither manufactures nor directly imports products that may be subject to tariffs, but the company is still performing its due diligence as it keeps an eye on the constantly evolving landscape.  As of May, there is a 125% tariff on products imported from China and a 10% general tariff on imported products from other countries.   “We’ve had a team that has been working to do a comprehensive review of all of our country of origin for...

Home Infusion Therapy, John Rademacher, Option Care, Tariff


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care executes in ‘dynamic environment,’ CEO says

May 1, 2025HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported net revenue of about $1.3 billion for the first quarter of 2025, an increase of 16.3% compared to the same period in 2024.  Net income was $46.7 million, up 7.7%, and adjusted net income was $67.1 million. Adjusted EBITDA was $111.8 million, up 13.7%.  “The Option Care Health team’s execution in a dynamic environment produced another great quarter of results,” said John Rademacher, CEO. “Overall, we expect...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care prioritizes practitioner model

February 28, 2025Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health in January closed on its acquisition of Intramed Plus, a South Carolina-based infusion provider, in a strategic move to broaden its advanced practitioner model, company execs say.  “We believe the advanced practitioner clinical model is highly complementary to our network of compounding pharmacies, and we intend to continue enhancing and expanding our infusion site network to incorporate broader clinical capabilities,” said CEO John...

Home Infusion Therapy, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care keeps growing

February 26, 2025HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of about $1.3 billion for the fourth quarter 2024, an increase of 19.7% compared to the same quarter in 2023.   Net revenue for the full year 2024 was $4.9 billion, up 16.2% compared to $4.3 billion for the full year 2023.  “The Option Care Health team’s execution produced solid financial results in the fourth quarter and full year 2024, demonstrating resilience in a dynamic and challenging period, while...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care pushes through disaster for strong quarter

November 1, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Despite disruption to its supply chain, Option Care Health’s quick and “aggressive” response allowed the provider to continue servicing patients, with minimal impact, CEO John Rademacher said.  In the aftermath of Hurricane Helene, flooding halted production of intravenous solution bags at the Baxter International plant in Marion, N.C.  “From the moment of the closure, needless to say, there were immediate actions that we took to not...

Home Infusion Therapy, Hurricane Helene, IV shortage, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care monitors ‘vigorous’ competition

March 1, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – The trend of payers integrating with providers, including Elevance Health’s recent acquisition of Paragon Healthcare, a Texas-based infusion provider, is a shift that Option Care Health is keeping a close eye on, says CEO John Rademacher.  “They're vigorous competitors and so we take that full view as we're approaching the marketplace,” he said on a recent call to discuss the company’s fourth quarter and full year earnings. “Our...

Home Infusion Therapy, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care delivers ‘strong results’

February 22, 2024HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $1.12 billion for the fourth quarter of 2023, an increase of 9.5% compared to the same quarter in 2022.  Revenue for the full year was $4.3 billion, up 9.1% compared to 2022. Gross profit for the quarter was $247.1 million and adjusted EBITDA was $111.6 million.  “The Option Care Health team delivered strong financial results in the fourth quarter and full year of 2023 and continued to execute on our commitment...

Home Infusion, John Rademacher, Option Care


Read Full Articlered right arrow icon